Evoq Remedies Ltd - Submission Of Revised Audited Financial Results For The Quarter And Year Ended On 31St March, 2022 Along With Auditor'S Report And Declaration

In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the Revised Audited Financial Results for the Quarter and Year ended on 31st March, 2022 along with Auditor's Report and Declaration due to Discrepancy related to Bifurcation of Trade payable not provided as per Accounting Standard Division. Further this is inform you that we were already submitted Audited Financial Results for the Quarter and Year ended on 31st March, 2022 as on 30th May, 2022, for the ratify the discrepancy in Financial Result we are submitting this revised Result. There are no change in Financial Result other than Bifurcation of Trade payable. Kindly take this revised result on your record and oblige us. Thanking You. Yours Faithfully,